Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid for Indwelling Pleural Catheter Duration in Breast Cancer
NCT01900730Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in breast cancer, malignant pleural effusion (MPE), sponsored by University of Texas MD Anderson Cancer Center. Started Jul 2014; status: terminated.
02
Drugs
valproic acid
03
Conditions
breast cancermalignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT01900730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01900730.